Health Care Down on Defensive Bias -- Health Care Roundup

Health-care companies fell, but not by as much as the broad market, amid a rotation back into the out-of-favor defensive sector.

Walgreen Boots Alliance surged after the drug-store chain's earnings topped modest Wall Street expectations.

Drugmaker AbbVie warned it will post a $3.5 billion impairment charge related to last year's $8.7 billion bet on Cerevel Therapeutics following the failure of the deal's key drug candidate, a schizophrenia treatment.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

01-10-25 1741ET